U.S. House · 117th Congress · H.R. 2815
BIOSIM Act
To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Kurt SchraderD-OR-5
- Introduced
- April 22, 2021, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (4)
3 Democrats, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Adam KinzingerR-IL-16
Signed on later
- G. K. ButterfieldD-NC-1June 29, 2021
- Mikie SherrillD-NJ-11June 29, 2021
- Kim SchrierD-WA-8July 22, 2021